[ Price : $8.95]
Medical school researchers say most DTC ads are for drugs that do not represent an advance over existing treatments.[ Price : $8.95]
FDA warns the South Miami, FL-based Larkin Community Hospital institutional review board about failing to adhere to statutory and ...[ Price : $8.95]
After three failed submissions, FDA accepts for review a Fabre-Kramer Pharmaceuticals NDA resubmission for Exxua (gepirone HCl) ex...[ Price : $8.95]
Federal Register notice: FDA determines for patent term extension purposes the regulatory review period for Acacia Pharmas Byfavo ...[ Price : $8.95]
The Service Employees International Union United Healthcare Workers West asks FDA to order five changes to certain Fresenius USA ...[ Price : $8.95]
Five King & Spalding attorneys review the nine advertising and promotion enforcement letters FDA issued in 2022.[ Price : $8.95]
FDA clears a Tidepool 510(k) for its Tidepool Loop, an automated insulin dosing app intended for managing Type 1 diabetes in patie...[ Price : $8.95]
An FDA clarifying notice says the agency will continue to make orphan drug exclusivity decisions based on a drugs specific approve...